173 related articles for article (PubMed ID: 31922055)
1. Current estimates of T cell kinetics in humans.
Macallan DC; Busch R; Asquith B
Curr Opin Syst Biol; 2019 Dec; 18():77-86. PubMed ID: 31922055
[TBL] [Abstract][Full Text] [Related]
2. The Rules of Human T Cell Fate
Costa Del Amo P; Debebe B; Razavi-Mohseni M; Nakaoka S; Worth A; Wallace D; Beverley P; Macallan D; Asquith B
Front Immunol; 2020; 11():573. PubMed ID: 32322253
[TBL] [Abstract][Full Text] [Related]
3. In vivo estimates of division and death rates of human T lymphocytes.
Mclean AR; Michie CA
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3707-11. PubMed ID: 7731969
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of in vivo proliferation and death of memory and naive CD8 T cells: parameter estimation based on 5-bromo-2'-deoxyuridine incorporation in spleen, lymph nodes, and bone marrow.
Parretta E; Cassese G; Santoni A; Guardiola J; Vecchio A; Di Rosa F
J Immunol; 2008 Jun; 180(11):7230-9. PubMed ID: 18490722
[TBL] [Abstract][Full Text] [Related]
5. Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and humans.
Westera L; Drylewicz J; den Braber I; Mugwagwa T; van der Maas I; Kwast L; Volman T; van de Weg-Schrijver EH; Bartha I; Spierenburg G; Gaiser K; Ackermans MT; Asquith B; de Boer RJ; Tesselaar K; Borghans JA
Blood; 2013 Sep; 122(13):2205-12. PubMed ID: 23945154
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of in vivo T cell kinetics: use of heavy isotope labelling in type 1 diabetes.
Bollyky JB; Long SA; Fitch M; Bollyky PL; Rieck M; Rogers R; Samuels PL; Sanda S; Buckner JH; Hellerstein MK; Greenbaum CJ
Clin Exp Immunol; 2013 Jun; 172(3):363-74. PubMed ID: 23600824
[TBL] [Abstract][Full Text] [Related]
7. Quantification of T-cell dynamics: from telomeres to DNA labeling.
Borghans JA; de Boer RJ
Immunol Rev; 2007 Apr; 216():35-47. PubMed ID: 17367333
[TBL] [Abstract][Full Text] [Related]
8. In-vivo assessment of T cell kinetics in individuals at risk for type 1 diabetes.
Hao W; Bahnson HT; Speake C; Cerosaletti K; Greenbaum CJ
Clin Exp Immunol; 2020 Jan; 199(1):50-55. PubMed ID: 31557315
[TBL] [Abstract][Full Text] [Related]
9. Reconciling Estimates of Cell Proliferation from Stable Isotope Labeling Experiments.
Ahmed R; Westera L; Drylewicz J; Elemans M; Zhang Y; Kelly E; Reljic R; Tesselaar K; de Boer RJ; Macallan DC; Borghans JA; Asquith B
PLoS Comput Biol; 2015 Oct; 11(10):e1004355. PubMed ID: 26437372
[TBL] [Abstract][Full Text] [Related]
10. Physiologically Based Simulations of Deuterated Glucose for Quantifying Cell Turnover in Humans.
Lahoz-Beneytez J; Schaller S; Macallan D; Eissing T; Niederalt C; Asquith B
Front Immunol; 2017; 8():474. PubMed ID: 28487698
[No Abstract] [Full Text] [Related]
11. In vivo deuterium labelling in mice supports a dynamic model for memory T-cell maintenance in the bone marrow.
Baliu-Piqué M; Otto SA; Borghans JAM; Tesselaar K
Immunol Lett; 2019 Jun; 210():29-32. PubMed ID: 31004681
[TBL] [Abstract][Full Text] [Related]
12. Clinical, immunological and treatment-related factors associated with normalised CD4+/CD8+ T-cell ratio: effect of naïve and memory T-cell subsets.
Tinago W; Coghlan E; Macken A; McAndrews J; Doak B; Prior-Fuller C; Lambert JS; Sheehan GJ; Mallon PW;
PLoS One; 2014; 9(5):e97011. PubMed ID: 24816636
[TBL] [Abstract][Full Text] [Related]
13. Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection.
Hellerstein MK; Hoh RA; Hanley MB; Cesar D; Lee D; Neese RA; McCune JM
J Clin Invest; 2003 Sep; 112(6):956-66. PubMed ID: 12975480
[TBL] [Abstract][Full Text] [Related]
14. Current best estimates for the average lifespans of mouse and human leukocytes: reviewing two decades of deuterium-labeling experiments.
Borghans JAM; Tesselaar K; de Boer RJ
Immunol Rev; 2018 Sep; 285(1):233-248. PubMed ID: 30129193
[TBL] [Abstract][Full Text] [Related]
15. Quantifying susceptibility of CD4+ stem memory T-cells to infection by laboratory adapted and clinical HIV-1 strains.
Flynn JK; Paukovics G; Cashin K; Borm K; Ellett A; Roche M; Jakobsen MR; Churchill MJ; Gorry PR
Viruses; 2014 Feb; 6(2):709-26. PubMed ID: 24517971
[TBL] [Abstract][Full Text] [Related]
16. Rapid turnover of effector-memory CD4(+) T cells in healthy humans.
Macallan DC; Wallace D; Zhang Y; De Lara C; Worth AT; Ghattas H; Griffin GE; Beverley PC; Tough DF
J Exp Med; 2004 Jul; 200(2):255-60. PubMed ID: 15249595
[TBL] [Abstract][Full Text] [Related]
17. Naïve subset develops the most important alloreactive response among human CD4+ T lymphocytes in human leukocyte antigen-identical related setting.
Chérel M; Choufi B; Trauet J; Cracco P; Dessaint JP; Yakoub-Agha I; Labalette M
Eur J Haematol; 2014 Jun; 92(6):491-6. PubMed ID: 24520815
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous quantification of natural and inducible regulatory T-cell subsets during interferon-β therapy of multiple sclerosis patients.
Chiarini M; Capra R; Serana F; Bertoli D; Sottini A; Giustini V; Scarpazza C; Rovaris M; Torri Clerici V; Ferraro D; Galgani S; Solaro C; Conti MZ; Visconti A; Imberti L;
J Transl Med; 2020 Apr; 18(1):169. PubMed ID: 32299447
[TBL] [Abstract][Full Text] [Related]
19. Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery.
Massanella M; Gómez-Mora E; Carrillo J; Curriu M; Ouchi D; Puig J; Negredo E; Cabrera C; Clotet B; Blanco J
J Transl Med; 2015 Jul; 13():230. PubMed ID: 26183947
[TBL] [Abstract][Full Text] [Related]
20. Central memory CD8+ T cells appear to have a shorter lifespan and reduced abundance as a function of HIV disease progression.
Ladell K; Hellerstein MK; Cesar D; Busch R; Boban D; McCune JM
J Immunol; 2008 Jun; 180(12):7907-18. PubMed ID: 18523254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
